The role of cubilin gene polymorphisms and their influence on 25(OH)D3 and 1,25(OH)2D3 plasma levels in type 1 diabetes patients

Background: Megalin and cubilin bind and internalize the 25(OH)D-3-DBP complex in the kidney. Once the complex is internalized, 25(OH)D-3 is released and activated to 1,25(OH)(2)D-3 the ligand for the vitamin D receptor (VDR). Supporting the important role of cubilin in this process recent findings showed that cubilin deficiency results in decrease of 25(OH)D-3 and 1,25(OH)(2)D-3 plasma levels. Methods: Two hundred T1D patients and healthy controls (n = 200) were genotyped for five polymorphisms (rs3740168, rs3740165, rs1801233, rs1801229 and rs2796835) within the cubilin gene. The polymorphisms were analyzed by RFLP or real time PCR. Statistic analyses were performed by using allele-wise and genotype-wise chi(2) testing by using BiAS software. A p-value <0.05 was considered as significant. Results: We found that the genotype "AA" of the rs3740165 was more frequent in T1D patients compared to healthy controls (26.7% vs. 5.1%, p = 4 x 10(-7)). Nevertheless no association between the rs3740165 polymorphism and the 25(OH)D-3 or 1,25(OH)(2)D-3 plasma levels was found. No association with the other studied polymorphisms was observed. Conclusion: Thus our findings reveal a novel association of the cubilin rs3740165 polymorphism with type 1 diabetes. Nevertheless how exactly this polymorphism could increase the risk to develop type 1 diabetes is subject for further investigations. (C) 2010 Published by Elsevier Ltd.